NCT04158128View on ClinicalTrials.gov

The Clinical Implications of Immune Checkpoint Pathways in PCNSL

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

October 27, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Lymphoma, B-Cell
Interventions
OTHER

non-intervention

non-interventional, prospective cohort study

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT04158128 - The Clinical Implications of Immune Checkpoint Pathways in PCNSL | Biotech Hunter | Biotech Hunter